BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19361553)

  • 1. Lipophilicity of potent porphyrin-based antioxidants: comparison of ortho and meta isomers of Mn(III) N-alkylpyridylporphyrins.
    Kos I; Rebouças JS; DeFreitas-Silva G; Salvemini D; Vujaskovic Z; Dewhirst MW; Spasojević I; Batinić-Haberle I
    Free Radic Biol Med; 2009 Jul; 47(1):72-8. PubMed ID: 19361553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins.
    Tovmasyan AG; Rajic Z; Spasojevic I; Reboucas JS; Chen X; Salvemini D; Sheng H; Warner DS; Benov L; Batinic-Haberle I
    Dalton Trans; 2011 Apr; 40(16):4111-21. PubMed ID: 21384047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipophilicity is a critical parameter that dominates the efficacy of metalloporphyrins in blocking the development of morphine antinociceptive tolerance through peroxynitrite-mediated pathways.
    Batinić-Haberle I; Ndengele MM; Cuzzocrea S; Rebouças JS; Spasojević I; Salvemini D
    Free Radic Biol Med; 2009 Jan; 46(2):212-9. PubMed ID: 18983908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+.
    Weitner T; Kos I; Sheng H; Tovmasyan A; Reboucas JS; Fan P; Warner DS; Vujaskovic Z; Batinic-Haberle I; Spasojevic I
    Free Radic Biol Med; 2013 May; 58():73-80. PubMed ID: 23328731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.
    Batinic-Haberle I; Rajic Z; Tovmasyan A; Reboucas JS; Ye X; Leong KW; Dewhirst MW; Vujaskovic Z; Benov L; Spasojevic I
    Free Radic Biol Med; 2011 Sep; 51(5):1035-53. PubMed ID: 21616142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of superoxide dismutase (SOD) mimics: the evaluation of the therapeutic potential of new cationic Mn porphyrins with linear and cyclic substituents.
    Tovmasyan A; Carballal S; Ghazaryan R; Melikyan L; Weitner T; Maia CG; Reboucas JS; Radi R; Spasojevic I; Benov L; Batinic-Haberle I
    Inorg Chem; 2014 Nov; 53(21):11467-83. PubMed ID: 25333724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin, combines superb potency and lipophilicity with low toxicity.
    Rajic Z; Tovmasyan A; Spasojevic I; Sheng H; Lu M; Li AM; Gralla EB; Warner DS; Benov L; Batinic-Haberle I
    Free Radic Biol Med; 2012 May; 52(9):1828-34. PubMed ID: 22336516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors.
    Keir ST; Dewhirst MW; Kirkpatrick JP; Bigner DD; Batinic-Haberle I
    Anticancer Agents Med Chem; 2011 Feb; 11(2):202-12. PubMed ID: 21291403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential coordination demands in Fe versus Mn water-soluble cationic metalloporphyrins translate into remarkably different aqueous redox chemistry and biology.
    Tovmasyan A; Weitner T; Sheng H; Lu M; Rajic Z; Warner DS; Spasojevic I; Reboucas JS; Benov L; Batinic-Haberle I
    Inorg Chem; 2013 May; 52(10):5677-91. PubMed ID: 23646875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of potent Mn porphyrin-based SOD mimics and peroxynitrite scavengers for pre-clinical mechanistic/therapeutic purposes.
    Rebouças JS; Spasojević I; Batinić-Haberle I
    J Pharm Biomed Anal; 2008 Nov; 48(3):1046-9. PubMed ID: 18804338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+).
    Gauter-Fleckenstein B; Reboucas JS; Fleckenstein K; Tovmasyan A; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z
    Redox Biol; 2014; 2():400-10. PubMed ID: 24624330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New class of potent catalysts of O2.-dismutation. Mn(III) ortho-methoxyethylpyridyl- and di-ortho-methoxyethylimidazolylporphyrins.
    Batinić-Haberle I; Spasojević I; Stevens RD; Hambright P; Neta P; Okado-Matsumoto A; Fridovich I
    Dalton Trans; 2004 Jun; (11):1696-702. PubMed ID: 15252564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pure MnTBAP selectively scavenges peroxynitrite over superoxide: comparison of pure and commercial MnTBAP samples to MnTE-2-PyP in two models of oxidative stress injury, an SOD-specific Escherichia coli model and carrageenan-induced pleurisy.
    Batinić-Haberle I; Cuzzocrea S; Rebouças JS; Ferrer-Sueta G; Mazzon E; Di Paola R; Radi R; Spasojević I; Benov L; Salvemini D
    Free Radic Biol Med; 2009 Jan; 46(2):192-201. PubMed ID: 19007878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate.
    Ye X; Fels D; Tovmasyan A; Aird KM; Dedeugd C; Allensworth JL; Kos I; Park W; Spasojevic I; Devi GR; Dewhirst MW; Leong KW; Batinic-Haberle I
    Free Radic Res; 2011 Nov; 45(11-12):1289-306. PubMed ID: 21859376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer therapeutic potential of Mn porphyrin/ascorbate system.
    Tovmasyan A; Sampaio RS; Boss MK; Bueno-Janice JC; Bader BH; Thomas M; Reboucas JS; Orr M; Chandler JD; Go YM; Jones DP; Venkatraman TN; Haberle S; Kyui N; Lascola CD; Dewhirst MW; Spasojevic I; Benov L; Batinic-Haberle I
    Free Radic Biol Med; 2015 Dec; 89():1231-47. PubMed ID: 26496207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manganese porphyrin redox state in endothelial cells: Resonance Raman studies and implications for antioxidant protection towards peroxynitrite.
    Carballal S; Valez V; Alvarez-Paggi D; Tovmasyan A; Batinic-Haberle I; Ferrer-Sueta G; Murgida DH; Radi R
    Free Radic Biol Med; 2018 Oct; 126():379-392. PubMed ID: 30144631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive evaluation of catalase-like activity of different classes of redox-active therapeutics.
    Tovmasyan A; Maia CG; Weitner T; Carballal S; Sampaio RS; Lieb D; Ghazaryan R; Ivanovic-Burmazovic I; Ferrer-Sueta G; Radi R; Reboucas JS; Spasojevic I; Benov L; Batinic-Haberle I
    Free Radic Biol Med; 2015 Sep; 86():308-21. PubMed ID: 26026699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective efficacy from a lipophilic redox-modulating Mn(III) N-Hexylpyridylporphyrin, MnTnHex-2-PyP: rodent models of ischemic stroke and subarachnoid hemorrhage.
    Sheng H; Spasojevic I; Tse HM; Jung JY; Hong J; Zhang Z; Piganelli JD; Batinic-Haberle I; Warner DS
    J Pharmacol Exp Ther; 2011 Sep; 338(3):906-16. PubMed ID: 21652782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High lipophilicity of meta Mn(III) N-alkylpyridylporphyrin-based superoxide dismutase mimics compensates for their lower antioxidant potency and makes them as effective as ortho analogues in protecting superoxide dismutase-deficient Escherichia coli.
    Kos I; Benov L; Spasojević I; Rebouças JS; Batinić-Haberle I
    J Med Chem; 2009 Dec; 52(23):7868-72. PubMed ID: 19954250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox modulation of oxidative stress by Mn porphyrin-based therapeutics: the effect of charge distribution.
    Rebouças JS; Spasojević I; Tjahjono DH; Richaud A; Méndez F; Benov L; Batinić-Haberle I
    Dalton Trans; 2008 Mar; (9):1233-42. PubMed ID: 18283384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.